pdufa.bio
HomeReadouts › May 2027

May 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for May 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← April 2027June 2027 →
8 readouts
TNGX · May 2027 (est.)
S095035: MTAP-deleted Solid Tumors
Awaiting data
VYGR · May 2027 (est.)
VY7523: Alzheimer's Disease (AD)
Awaiting dataupdated 7mo ago
REGN · May 2027 (est.)
Cemiplimab: Recurrent Ovarian Cancer
REGN · May 2027 (est.)
Cemiplimab: Non-Small Cell Lung Cancer
FDMT · May 2027 (est.)
4D-150 IVT: Choroideremia
Awaiting dataupdated 13mo ago
MBX · May 2027 (est.)
MBX 2109: Hypoparathyroidism
Awaiting dataupdated 8mo ago
BIIB · May 2027 (est.)
Felzartamab: Immunoglobulin A Nephropathy (IgAN)
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).